Burn Shock: Clinical Trials

5 trials for Burn Shock, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Unknown 1
Phase 21Completed 1

Follow Burn Shock: new trials by email Literature Review of Burn Shock trials Research Report on Burn Shock

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enteral Resuscitation Nepal
Oral Rehydration Solution, Lactated Ringer - Burn Body Region Unspecified, Burn Shock
Phase 3UnknownNepal Health Research Council2402022-12-082023-10-31
Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn Patients
intravenous immunoglobulin - Burn Shock
Phase 2 / Phase 3CompletedCairo University302021-10-102022-11-15
Enteral Resuscitation Nepal (Pilot Study)
Oral Rehydration Solution, Lactated Ringer - Burn Body Region Unspecified, Burn Shock
Phase 3CompletedUniversity of Washington302021-09-302023-10-11
Evaluation of Sublingual Microcirculation in Burn During Resuscitation
Microcirculation cytocam - Burn Shock
UnknownCairo University302021-02-012021-10-27
Low Dose Vitamin C in Burns >20% Compared to Previous Studies With High Dose Vitamin C
Vitamin C - Burns, Ascorbic Acid Deficiency
CompletedArrowhead Regional Medical Center542020-12-122022-11-10

Narrower conditions

Burns (3)  ·  Osteoarthritis (2)  ·  Ascorbic Acid Deficiency (1)

Broader conditions

Wounds and Injuries (3)  ·  Arthritis (2)  ·  Joint Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Rheumatic Diseases (2)  ·  Avitaminosis (1)  ·  Deficiency Diseases (1)  ·  Malnutrition (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Ringer's Lactate (2)  ·  World Health Organization oral rehydration solution (2)  ·  Ascorbic Acid (1)  ·  Immunoglobulins, Intravenous (1)

Sponsors

Cairo University (2)  ·  Arrowhead Regional Medical Center (1)  ·  Nepal Health Research Council (1)  ·  University of Washington (1)

Countries

Egypt (2)  ·  Nepal (2)  ·  United States (1)

Top investigators

Aldin Malkoc, MD (1)  ·  David T Wong, MD (1)  ·  Hanan Mostafa (1)  ·  Kajal Mehta, MD, MPH (1)  ·  Kiran K Nakarmi, MBBS,MCh (1)

Results publications

PMID 17091076, PMID 24235922, PMID 39577105, PMID 39798346, PMID 5496482, PMID 8300697

NIH funding

D43TW009345 (1)